Toxoplasmosis in HIV/AIDS patients: A current situation

Japanese Journal of Infectious Diseases

Volumn 57, Issue 4, 2004, Pages 160-165

  Nissapatorn, Veeranoot ^b   Lee, Christopher ^a   Quek, Kia Fatt ^b   Leong, Chee Loon ^a   Mahmud, Rohela ^b   Abdullah, Khairul Anuar ^b  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; ENCEPHALITIS; FEMALE; FOLLOW UP; HEADACHE; HEALTH BEHAVIOR; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORTALITY; NONHUMAN; OCCUPATION; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; TOXOPLASMA; TOXOPLASMOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; HIV INFECTIONS; HUMANS; MALAYSIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CEREBRAL;

EID: 4644240974     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Israelski, D. M. and Remington, J. S. (1992): AIDS-associated toxoplasmosis. p. 319-345. In Sande, M. A. and Volberding, P. A. (ed.), The Medical Management of AIDS. WB Saunders, Philadelphia.
2. Luft, B. J. and Remington, J. S. (1992): Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis., 15, 211-222.
3. Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D., Bosler, E. M., Bourland, D. D. 3rd., Uttamchandani, R., Fuhrer, J., Jacobson, J., Morlat, P., Jean-Louis, V., Remington, J. S. and Members of the ACTG 077p/ANRS 009 study team (1993): Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med., 329, 995-1000.
4. Shamilah, H., Lokman Hakim, S., Nooer Azian, M. Y., Malkith, K. and Yusri, M. Y. (2001): Seroprevalence of Toxoplasma gondii antibodies in HIV positive and negative patients using the immunofluorescence antibody test (IFAT) methods. Trop. Biomed., 18, 137-141.
5. Nissapatorn, V., Kamarulzaman, A., Init, I., Tan, L. H., Rohela, M., Norliza, A., Chan, L. L., Latt, H. M., Khairul Anuar, A. and Quek, K. F. (2002): Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med. J. Malaysia, 57, 304-310.
6. Nissapatorn, V., Lee, C. K. C. and Khairul, A. A. (2003): Seroprevalence of toxoplasmosis among AIDS patients in Hospital Kuala Lumpur, 2001. Singapore Med. J., 44, 194-196.
7. Nissapatorn, V., Lee, C. K. C., Cho, S. M., Rohela, M., Khairul Anuar, A., Quek, K. F. and Latt, H. M. (2003): Toxoplasmosis in HIV/AIDS patients in Malaysia. Southeast Asian J. Trop. Med. Public Health, 34 (Suppl. 2), 80-85.
8. Galvan Ramirez, M. L., Valdez Alvarado, V., Vargas Gutierrez, G., Jimenez Gonzalez, O., Garcia Cosio, C. and Vielma Sandoval, M. (1997): Prevalence of IgG and IgM anti-Toxoplasma antibodies in patients with HIV and acquired immunodeficiency syndrome (AIDS). Rev. Soc. Bras. Med. Trop., 30, 465-467.
9. Boto de Los Bueis, A., Vega Aleman, D., Galvez Acebal, J., Merico Munoz, D., Creagh Cerquera, R. and Pujol de la Llave, E. (1998): Prevalence of latent Toxoplasma infection in HIV infection patients. Ann. Med. Intern., 15, 298-300.
10. Wanachiwanawin, D., Sutthent, R., Chokephaibulkit, K., Mahakittikun, V., Ongrotchanakun, J. and Monkong, N. (2001): Toxoplasma gondii antibodies in HIV and non-HIV infected Thai pregnant women. Asian. Pac. J. Aller. Immunol., 19, 291-293.
11. Falusi, O., French, A. L., Seaberg, E. C., Tien, P. C., Watts, D. H., Minkoff, H., Piessens, E., Kovacs, A., Anastos, K. and Cohen, M. H. (2002): Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency infection. Clin. Infect. Dis., 35, 1414-1417.
12. Leport, C. and Remington, J. S. (1992). Toxoplasmosis in AIDS. Presse Med., 21, 1165-1171.
13. Richards, F. O. Jr., Kovacs, J. A. and Luft, B. J. (1995): Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin. Infect. Dis., 21(Suppl.), S49-56.
14. Holliman, R. E. (1990): Serological study of the prevalence of toxoplasmosis in symptomatic patients infected with human immunodeficiency virus. Epidemiol. Infect., 105, 415-418.
15. Feldman, H. A. and Miller, L. T. (1965): Serologic study of toxoplasmosis prevalence. Am. J. Hyg., 64, 320-335.
16. Mariuz, P. and Steigbifel, R. T. (2001): Toxoplasma infection in HIV-infected patients. p. 147-177. In Joynson, D. H. M. and Wreghitt, T. G. (ed.), Toxoplasmosis. Cambridge University Press, Cambridge.
17. Gross, U., Kempf, M. C., Seeber, F., Luder, C. G., Lugert, R. and Bohne, W. (1997): Reactivation of chronic toxoplasmosis: is there a link to strain-specific differences in the parasite? Behring Inst. Mitt., 99, 97-106.
18. Torre, D., Zeroli, C., Ferrario, G., Pugliese, A., Speranza, F., Orani, A., Casari, S., Bassi, P., Poggio, A., Carosi, G. P. and Fiori, G. P. (1999): Levels of nitric oxide, gamma interferon and interleukin-12 in AIDS patients with toxoplasmic encephalitis. Infection, 27, 218-220.
19. Sarciron, M. E. and Gherardi, A. (2000): Cytokines involved in toxoplasmic encephalitis. Scand. J. Immunol., 52, 534-543.
20. Ragnaud, J. M., Morlat, P., Dupon, M., Lacoste, D., Pellegrin, J. L. and Chene, G. (1993): Cerebral toxoplasmosis in AIDS patients. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania. Presse Med., 22, 903-908.
21. Ferrer, S., Fuentes, I., Domingo, P., Munoz, C., Iranzo, A., Barrio, J. L., Fuster, M., Ris, J., Sambeat, M. A., Cadafalch, J. and Nolla, J. (1996): Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients. Ann. Med. Intern., 13, 4-8.
22. Bouree, P., Dumazedier, D., Magdeleine, C. and Sobesky, G. (1997): Cerebral toxoplasmosis and AIDS in Martinique. Med. Trop., 57, 259-261.
23. Raffi, F., Aboulker, J. P., Michelet, C., Reliquet, V., Pelloux, H., Huart, A., Poizot-Martin, I., Morlat, P., Dupas, B., Mussini, J. M. and Leport, C. (1997) : A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group. AIDS, 11, 177-184.
24. Chaddha, D. S., Kalra, S. P., Singh, A. P., Gupta, R. M. and Sancheetee, P. C. (1999): Toxoplasmic encephalitis in acquired immunodeficiency syndrome. J. Assoc. Physician India, 47, 680-684.
25. Katzenstein, T. L., Oster, S. and Kiss, K. (1998): Toxoplasmic encephalitis with atypical manifestation and normal CT. Ugeskr. Laeger, 160, 4430-4432 (in Danish).
26. Nakazaki, S., Saeki, N., Itoh, S., Osato, K., Watanabe, O., Hamada, N., Mitsuhashi, H., Shin, H., Kiuchi, I., Kobayashi, C., Yano, A. and Yamaura, A. (2000): Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome-four case reports. Neurol. Med. Chir., 40, 120-123.
27. Spausta, G., Ciarkowska, J., Wiczkowski, A., Adamek,B. and Beniowski, M. (2003): Anti-Toxoplasma gondii IgG antibodies in HIV-infected patients. Pol. Merkuriusz Lek., 14, 233-235 (in Polish).
28. Gervasoni, C., Ridolfo, A., Bini, T., Mena, M., Testa, L., Moscatelli, G. and D' Arminio Monforte, A. (1995): Cerebral toxoplasmosis in AIDS. Infez. Med., 3, 71-76 (in Italian).
29. Levy, R. M., Janssen, R. S., Bush, T. J. and Rosenblum, M. L. (1988): Neuroepidemiology of acquired immunodeficiency syndrome. J. Acquir. Immun. Defic. Syndr., 1, 31-40.
30. del Rio-Chiriboga, C., Orzechowski-Rallo, A. and Sanchez-Mejorada, G. (1997): Toxoplasmosis of the central nervous system in patients with AIDS in Mexico. Arch. Med. Res., 28, 527-530.
31. Nascimento, L. V., Stollar, F., Tavares, L. B., Cavasini, C. E., Maia, I. L., Cordeiro, J. A. and Ferreira, M. U. (2001): Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case-control study in Brazil. Ann. Trop. Med. Parasitol., 95, 587-593.
32. Furrer, H., Opravil, M., Bernasconi, E., Telenti, A. and Egger, M. (2000): Stopping primary prophylaxis in HIV-1 infected patients at high risk of Toxoplasma encephalitis. Swiss HIV Cohort Study. Lancet, 355, 2217-2218.
33. Baltaci, A. K., Bediz, C. S., Mogulkoc, R., Kurtoglu, E. and Pekel, A. (2003): Effect of zinc and melatonin supplementation on cellular immunity in rats with toxoplasmosis. Biol. Trace Elem. Res., 96, 237-245.
34. Fung, H. B. and Kirschenbaum, H. L. (1996): Treatment regimens for patients with toxoplasmic encephalitis. Clin. Ther., 18, 1037-1056.
35. Vallat-Decouvelaere, A. V., Chretien, F., Lorin de la Grandmaison, G., Carlier, R., Force, G. and Grey, F. (2003): The neuropathology of HIV infection in the era of highly active antiretroviral therapy. Ann. Pathol., 23, 408-423.
36. Walckenaer, G., Leport, C., Longuet, P., Perronne, C., Lacassin, F. and Vilde, J. L. (1994): Recurrence of cerebral toxoplasmosis in 15 AIDS patients. Ann. Med. Intern., 145, 181-184.
37. Zeller, V., Truffot, C., Agher, R., Bossi, P., Tubiana, R., Caumes, E., Jouan, M., Bricaire, F. and Katlama, C. (2002): Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis. Clin. Infect. Dis., 34, 662-667.
38. Podzamczer, D., Miro, J. M., Ferrer, E., Gatell, J. M., Ramon, J. M., Ribera, E., Sirera, G., Cruceta, A., Knobel, H., Domingo, P., Polo, R., Leyes, M., Cosin, J., Farinas, M. C., Arrizabalaga, J., Martinez-Lacasa, J. and Gudiol, F. (2000): Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. Eur. J. Clin. Microbiol. Infect. Dis., 19, 89-95.